GlassScriptPhysician profile
Mallory L Heath
NPI 1215225909
$6,756.84
in general payments reported to CMS, 2019-2025
21 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $706 · 2022: $1,312 · 2023: $1,499 · 2024: $1,703 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,586 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,585.50 |
| Education | $153.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,956.07 | 2021-2025 | |
| Galderma Laboratories, L.P. | $1,060.99 | 2022-2025 | Nemluvio, Aklief |
| Genzyme Corporation | $979.20 | 2021-2025 | |
| Janssen Biotech, INC. | $736.44 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $606.25 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $329.33 | 2022-2024 | Sotyktu |
| Sanofi-Aventis U.S. LLC | $278.98 | 2021-2023 | |
| Leo Pharma INC. | $151.25 | 2022-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $139.45 | 2023-2024 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $112.43 | 2023-2025 | Zoryve |
| Pfizer INC. | $78.91 | 2025 | |
| Incyte Corporation | $75.87 | 2022-2025 | Opzelura |
| Amgen INC. | $71.28 | 2022-2024 | Otezla |
| Lilly USA, LLC | $52.69 | 2022-2023 | Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $49.80 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $16.34 | 2024 | Ogsiveo |
| Glaxosmithkline, LLC. | $16.32 | 2025 | Arexvy, Shingrix |
| Botanix Sb INC | $14.62 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $13.69 | 2023 | Vtama |
| Genentech USA, INC. | $13.24 | 2022 | |
| Organon LLC | $3.69 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.